Method and pharmaceutical composition for treating Crohn's disease
It is an object of the present invention to provide a pharmaceutical composition comprising an anti-fractalkine antibody that provides therapeutically effective improvement to Crohn's disease, after the administration thereof to a human subject, and a method for treating Crohn's disease. P...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Baba, Hiroko Yasuda, Nobuyuki Oketani, Kiyoshi Mori, Masahiko Nakano, Tomohisa |
| description | It is an object of the present invention to provide a pharmaceutical composition comprising an anti-fractalkine antibody that provides therapeutically effective improvement to Crohn's disease, after the administration thereof to a human subject, and a method for treating Crohn's disease. Provided is a pharmaceutical composition for treating Crohn's disease. The present pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient, and is used, such that the anti-fractalkine antibody is intravenously administered to a human at a dose of at least 10 mg/kg of human body weight in a method for treating Crohn's disease. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11052150B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11052150B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11052150B23</originalsourceid><addsrcrecordid>eNrjZHDyTS3JyE9RSMxLUSjISCzKTUxOLS3JTE7MUUjOzy3IL84syczPU0jLL1IoKUpNLMnMS1dwLsrPyFMvVkjJLE5NLE7lYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQVAE_NSS-JDgw0NDUyNDE0NnIyMiVEDAFVLMj0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Method and pharmaceutical composition for treating Crohn's disease</title><source>esp@cenet</source><creator>Baba, Hiroko ; Yasuda, Nobuyuki ; Oketani, Kiyoshi ; Mori, Masahiko ; Nakano, Tomohisa</creator><creatorcontrib>Baba, Hiroko ; Yasuda, Nobuyuki ; Oketani, Kiyoshi ; Mori, Masahiko ; Nakano, Tomohisa</creatorcontrib><description>It is an object of the present invention to provide a pharmaceutical composition comprising an anti-fractalkine antibody that provides therapeutically effective improvement to Crohn's disease, after the administration thereof to a human subject, and a method for treating Crohn's disease. Provided is a pharmaceutical composition for treating Crohn's disease. The present pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient, and is used, such that the anti-fractalkine antibody is intravenously administered to a human at a dose of at least 10 mg/kg of human body weight in a method for treating Crohn's disease.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210706&DB=EPODOC&CC=US&NR=11052150B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210706&DB=EPODOC&CC=US&NR=11052150B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Baba, Hiroko</creatorcontrib><creatorcontrib>Yasuda, Nobuyuki</creatorcontrib><creatorcontrib>Oketani, Kiyoshi</creatorcontrib><creatorcontrib>Mori, Masahiko</creatorcontrib><creatorcontrib>Nakano, Tomohisa</creatorcontrib><title>Method and pharmaceutical composition for treating Crohn's disease</title><description>It is an object of the present invention to provide a pharmaceutical composition comprising an anti-fractalkine antibody that provides therapeutically effective improvement to Crohn's disease, after the administration thereof to a human subject, and a method for treating Crohn's disease. Provided is a pharmaceutical composition for treating Crohn's disease. The present pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient, and is used, such that the anti-fractalkine antibody is intravenously administered to a human at a dose of at least 10 mg/kg of human body weight in a method for treating Crohn's disease.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDyTS3JyE9RSMxLUSjISCzKTUxOLS3JTE7MUUjOzy3IL84syczPU0jLL1IoKUpNLMnMS1dwLsrPyFMvVkjJLE5NLE7lYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQVAE_NSS-JDgw0NDUyNDE0NnIyMiVEDAFVLMj0</recordid><startdate>20210706</startdate><enddate>20210706</enddate><creator>Baba, Hiroko</creator><creator>Yasuda, Nobuyuki</creator><creator>Oketani, Kiyoshi</creator><creator>Mori, Masahiko</creator><creator>Nakano, Tomohisa</creator><scope>EVB</scope></search><sort><creationdate>20210706</creationdate><title>Method and pharmaceutical composition for treating Crohn's disease</title><author>Baba, Hiroko ; Yasuda, Nobuyuki ; Oketani, Kiyoshi ; Mori, Masahiko ; Nakano, Tomohisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11052150B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Baba, Hiroko</creatorcontrib><creatorcontrib>Yasuda, Nobuyuki</creatorcontrib><creatorcontrib>Oketani, Kiyoshi</creatorcontrib><creatorcontrib>Mori, Masahiko</creatorcontrib><creatorcontrib>Nakano, Tomohisa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Baba, Hiroko</au><au>Yasuda, Nobuyuki</au><au>Oketani, Kiyoshi</au><au>Mori, Masahiko</au><au>Nakano, Tomohisa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Method and pharmaceutical composition for treating Crohn's disease</title><date>2021-07-06</date><risdate>2021</risdate><abstract>It is an object of the present invention to provide a pharmaceutical composition comprising an anti-fractalkine antibody that provides therapeutically effective improvement to Crohn's disease, after the administration thereof to a human subject, and a method for treating Crohn's disease. Provided is a pharmaceutical composition for treating Crohn's disease. The present pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient, and is used, such that the anti-fractalkine antibody is intravenously administered to a human at a dose of at least 10 mg/kg of human body weight in a method for treating Crohn's disease.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11052150B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Method and pharmaceutical composition for treating Crohn's disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T11%3A05%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Baba,%20Hiroko&rft.date=2021-07-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11052150B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |